Harvard Bioscience Inc (HBIO)
2.26
+0.10
(+4.63%)
USD |
NASDAQ |
Nov 22, 16:00
2.26
0.00 (0.00%)
After-Hours: 16:21
Harvard Bioscience Total Assets (Quarterly): 131.24M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 131.24M |
| June 30, 2024 | 128.91M |
| March 31, 2024 | 133.16M |
| December 31, 2023 | 137.37M |
| September 30, 2023 | 139.74M |
| June 30, 2023 | 142.90M |
| March 31, 2023 | 145.58M |
| December 31, 2022 | 145.36M |
| September 30, 2022 | 147.01M |
| June 30, 2022 | 155.27M |
| March 31, 2022 | 158.04M |
| December 31, 2021 | 162.34M |
| September 30, 2021 | 153.87M |
| June 30, 2021 | 153.97M |
| March 31, 2021 | 151.25M |
| December 31, 2020 | 156.25M |
| September 30, 2020 | 149.61M |
| June 30, 2020 | 150.68M |
| March 31, 2020 | 156.26M |
| December 31, 2019 | 164.87M |
| September 30, 2019 | 162.78M |
| June 30, 2019 | 166.24M |
| March 31, 2019 | 171.34M |
| December 31, 2018 | 168.61M |
| September 30, 2018 | 165.04M |
| Date | Value |
|---|---|
| June 30, 2018 | 165.05M |
| March 31, 2018 | 170.95M |
| December 31, 2017 | 109.35M |
| September 30, 2017 | 110.68M |
| June 30, 2017 | 108.86M |
| March 31, 2017 | 107.40M |
| December 31, 2016 | 107.76M |
| September 30, 2016 | 112.18M |
| June 30, 2016 | 114.08M |
| March 31, 2016 | 117.88M |
| December 31, 2015 | 120.05M |
| September 30, 2015 | 133.56M |
| June 30, 2015 | 138.58M |
| March 31, 2015 | 134.12M |
| December 31, 2014 | 135.92M |
| September 30, 2014 | 136.13M |
| June 30, 2014 | 137.71M |
| March 31, 2014 | 135.29M |
| December 31, 2013 | 135.46M |
| September 30, 2013 | 148.34M |
| June 30, 2013 | 146.05M |
| March 31, 2013 | 135.44M |
| December 31, 2012 | 133.48M |
| September 30, 2012 | 130.58M |
| June 30, 2012 | 129.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
128.91M
Minimum
Jun 2024
164.87M
Maximum
Dec 2019
148.18M
Average
150.15M
Median
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 6.113B |
| Azenta Inc | 2.100B |
| Bionano Genomics Inc | 87.36M |
| Akoya Biosciences Inc | 129.97M |
| Singular Genomics Systems Inc | 186.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 65.92M |
| Shareholders Equity (Quarterly) | 65.32M |
| Debt to Equity Ratio | 0.5796 |
| Current Ratio | 2.057 |
| Net Debt Paydown Yield | 0.61% |